Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Antimalarial and Covid 19 in Rheumatoid Arthritis

NCT04389320 is registered in ClinicalTrials.gov with Assiut University as lead sponsor.

NCT NCT04389320
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04389320 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Antimalarial and Covid 19 in Rheumatoid Arthritis
Lead sponsor
Assiut University
Phase
Observational
Overall status
Completed
Start date
March 15, 2020
Completion date
May 1, 2020
Enrollment
60 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

rheumatoid arthritis